Key result
Moderate early SBP reduction linked to ~38% lower odds of death or major disability post-stroke.
Why the study?
The relationships between the magnitude of SBP reduction and achieved SBP in the acute phase of ischemic stroke and subsequent clinical outcomes needed evaluation.
Does a moderate magnitude of SBP reduction and lower early achieved SBP improve functional outcomes in patients with acute ischemic stroke?
Cohort (n=3,923)
Single-blind, blinded end points
Yes
Does a moderate magnitude of SBP reduction and lower early achieved SBP improve functional outcomes in patients with acute ischemic stroke?
A moderate proportional reduction in systolic blood pressure (11-20%) and achieving an early target SBP <130 mm Hg in the acute phase of ischemic stroke are associated with improved 3-month clinical outcomes.
Supports moderate early SBP reduction in acute ischemic stroke; hypothesis-generating and requires randomized confirmation before practice change.
Background We aimed to evaluate the relationships between the magnitude of systolic blood pressure (SBP) reduction and achieved SBP in the acute phase of ischemic stroke onset and subsequent clinical outcomes. Methods and Results This study was a secondary analysis of CATIS (China Antihypertensive Trial in Acute Ischemic Stroke), a multicenter randomized controlled trial of 4071 patients with acute ischemic stroke. SBP reduction was defined as the proportional SBP changes from baseline to 24 hours after randomization, and achieved SBP was the mean of SBP measurements at day 7. The study outcomes included functional outcome of death or major disability (modified Rankin Scale score ≥3), death, and cardiovascular events at 3 months after recruitment. Compared with the reference group of increase or no change in SBP within the first 24 hours, the odds ratios (95% CIs) of functional outcome of death or major disability were 0.62 (0.47-0.83) and 0.61 (0.42-0.87) for the reduction of 11% to 20% and >20%, respectively. Compared with participants in highest achieved SBP group (≥160 mm Hg) at day 7, odds ratios or hazard ratios of lower achieved SBP (<130 mm Hg) were 0.54 (95% CI, 0.37-0.80) for functional outcome, and 0.36 (95% CI, 0.17-0.80) for death or cardiovascular events. Conclusions A moderate magnitude of SBP reduction and a lower early achieved SBP were associated with a decreased risk of poor functional outcome, death, and cardiovascular events after acute ischemic stroke. Further studies are warranted to confirm these findings. REGISTRATION: URL: ClinicalTrials.gov; Unique identifier: NCT01840072.
No takes yet. Share an insight, caveat, or question.
Zhai et al. (2023) conducted a cohort in Acute ischemic stroke (n=3,923). SBP reduction of 11% to 20% within 24 hours vs. Increase or no change in SBP (≤0%) within 24 hours was evaluated on Composite of death and major disability (modified Rankin Scale score ≥3) (OR 0.62, 95% CI 0.47-0.83). A moderate systolic blood pressure reduction of 11% to 20% within the first 24 hours of acute ischemic stroke was associated with a 38% reduction in the odds of death or major disability compared to no reduction or an increase in blood pressure.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: